As of the latest Form 4 filed Jul 6, 2026.
What Curtiss-Wright Corporation insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 30 most recent filings for CW.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | 2026-07-06 | McDonald George P. Executive VP and Corporate Sec | AAward | +25.00 | $634.88 | $15.9K | No | Form 4 ↗ |
| 2026-07-06 | 2026-07-06 | Watts John C EVP & Chief Growth Officer | AAward | +9.00 | $634.88 | $5.71K | No | Form 4 ↗ |
| 2026-07-06 | 2026-07-06 | Rayment Kevin Executive VP and COO | AAward | +26.00 | $634.88 | $16.5K | No | Form 4 ↗ |
| 2026-07-06 | 2026-07-06 | Farkas K Christopher Executive VP and CFO | AAward | +21.00 | $634.88 | $13.3K | No | Form 4 ↗ |
| 2026-07-06 | 2026-07-06 | Bamford Lynn M Chair and CEO | AAward | +17.00 | $634.88 | $10.8K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-15 | Watts John C EVP & Chief Growth Officer | SSale | −200.00 | $770.56 | $154K | Yes (planned) | Form 4 ↗ |
| 2026-06-15 | 2026-06-12 | Bamford Lynn M Chair and CEO | SSale | −2.50K | $758.20 | $1.90M | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-09 | Ogilby Gary A Senior VP & Corp Controller | SSale | −399.00 | $721.95 | $288K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-09 | Bamford Lynn M Chair and CEO | SSale | −2.50K | $721.72 | $1.80M | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-06-01 | Wallace Peter C Director | AAward | +221.00 | $719.99 | $159K | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | MINOR GLENDA J Director | AAward | +20.00 | $747.61 | $15.0K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-27 | Watts John C EVP & Chief Growth Officer | SSale | −220.00 | $752.91 | $166K | Yes (planned) | Form 4 ↗ |
| 2026-05-14 | 2026-05-12 | MINOR GLENDA J Director | AAward | +221.00 | $735.34 | $163K | No | Form 4 ↗ |
| 2026-05-11 | 2026-05-07 | Lyash Jeffrey J. Director | AAward | +48.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-19 | 2026-03-18 | Ogilby Gary A Senior VP & Corp Controller | SSale | −252.00 | $689.14 | $174K | Yes (planned) | Form 4 ↗ |
| 2026-03-19 | 2026-03-18 | Farkas K Christopher Executive VP and CFO | SSale | −1.26K | $689.69 | $872K | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Watts John C EVP & Chief Growth Officer | SSale | −220.00 | $678.11 | $149K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Freda Robert F Senior VP & Treasurer | SSale | −140.00 | $678.61 | $95.0K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Ogilby Gary A Senior VP & Corp Controller | SSale | −148.00 | $678.30 | $100K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | McDonald George P. Executive VP and Corporate Sec | SSale | −151.00 | $678.07 | $102K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Rayment Kevin Executive VP and COO | SSale | −907.00 | $677.38 | $614K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Farkas K Christopher Executive VP and CFO | SSale | −918.00 | $677.46 | $622K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Bamford Lynn M Chair and CEO | SSale | −3.23K | $676.70 | $2.18M | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Watts John C EVP & Chief Growth Officer | MExercise | +512.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Freda Robert F Senior VP & Treasurer | MExercise | +296.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Ogilby Gary A Senior VP & Corp Controller | MExercise | +400.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | McDonald George P. Executive VP and Corporate Sec | MExercise | +350.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Rayment Kevin Executive VP and COO | MExercise | +2.50K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Farkas K Christopher Executive VP and CFO | MExercise | +2.18K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Bamford Lynn M Chair and CEO | MExercise | +7.67K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CW’s full analysis or the market-wide insider trading feed. The tabs above jump to CW’s other SEC data.
Source: SEC Form 4 filings for CW, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.